First Trust Advisors’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-101,876
Closed -$1.34M 2436
2023
Q3
$1.34M Sell
101,876
-5,749
-5% -$105K ﹤0.01% 1851
2023
Q2
$2.75M Buy
+107,625
New +$2.78M ﹤0.01% 1551

Other funds holding TMCI

First Trust Advisors's TMCI Position: Q4 2023 in Review

First Trust Advisors sold out of Treace Medical Concepts (TMCI) in Q4 2023, closing a stake of 101,876 shares — an estimated $1.34M sold.

First Trust Advisors first reported a position in TMCI in Q2 2023 and held it in 2 quarters. The position peaked at $2.75M in Q2 2023. 127 funds tracked by Wall St. Rank hold TMCI as of Q4 2023.

  • First Trust Advisors reported no remaining Treace Medical Concepts position as of Q4 2023 after selling out during the quarter.
  • First Trust Advisors sold 101,876 Treace Medical Concepts shares in Q4 2023, an estimated $1.34M.
  • First Trust Advisors first reported a position in Treace Medical Concepts in Q2 2023 and held it in 2 quarters.
  • First Trust Advisors's Treace Medical Concepts position peaked at $2.75M in Q2 2023.
  • 127 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2023.

Based on First Trust Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.